KMT vs. CPRX
KMT (Kennametal Inc.) and CPRX (Catalyst Pharmaceuticals, Inc.) are both stocks. KMT operates in Tools & Accessories (Industrials), while CPRX operates in Biotechnology (Healthcare). Over the past 10 years, KMT returned 5.73%/yr vs 44.91%/yr for CPRX. Their 0.18 correlation means their historical movements had little consistent relationship.
Performance
KMT vs. CPRX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, KMT achieves a 20.81% return, which is significantly lower than CPRX's 34.92% return. Over the past 10 years, KMT has underperformed CPRX with an annualized return of 5.73%, while CPRX has yielded a comparatively higher 44.91% annualized return.
KMT
- 1D
- 1.95%
- 1M
- 1.43%
- 6M
- -0.20%
- YTD
- 20.81%
- 1Y
- 43.39%
- 3Y*
- 8.86%
- 5Y*
- 1.67%
- 10Y*
- 5.73%
- ALL TIME*
- 6.82%
CPRX
- 1D
- 0.00%
- 1M
- 0.13%
- 6M
- 29.59%
- YTD
- 34.92%
- 1Y
- 49.10%
- 3Y*
- 32.72%
- 5Y*
- 41.46%
- 10Y*
- 44.91%
- ALL TIME*
- 8.79%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $30.68M | $29.46M | $44.86M |
KMT vs. CPRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
KMT Kennametal Inc. | 20.81% | 22.58% | -3.95% | 10.48% | -30.97% | 1.20% | 1.08% | 13.49% | -29.88% | 58.13% |
CPRX Catalyst Pharmaceuticals, Inc. | 34.92% | 11.84% | 24.15% | -9.62% | 174.74% | 102.69% | -10.93% | 95.31% | -50.90% | 272.38% |
Correlation
The correlation between KMT and CPRX is 0.27, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.27 |
Correlation (3Y) Balances recent behavior with more history. | 0.33 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.33 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.27 |
Correlation (All Time) Calculated using the full available price history since Nov 8, 2006 | 0.18 |
The correlation between KMT and CPRX shifts across timeframes, from 0.18 (all time) to 0.33 (3 years), reflecting how their relationship changes across market environments.
Fundamentals
KMT:
$2.59B
CPRX:
$3.85B
KMT:
$1.78
CPRX:
$1.74
KMT:
19.10
CPRX:
18.08
KMT:
0.57
CPRX:
0.32
KMT:
1.22
CPRX:
6.70
KMT:
1.88
CPRX:
3.95
KMT:
$2.14B
CPRX:
$596.96M
KMT:
$682.06M
CPRX:
$378.23M
KMT:
$249.28M
CPRX:
$313.50M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
KMT vs. CPRX — Risk / Return Rank
KMT
CPRX
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
KMT vs. CPRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Kennametal Inc. (KMT) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| KMT | CPRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.66 | ||
| Sortino ratioReturn per unit of downside risk | -0.72 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 1.31 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | 1.57 | 3.52 | -1.95 |
| Martin ratioReturn relative to average drawdown | 3.23 | 9.42 | -6.19 |
Loading charts...
Drawdowns
KMT vs. CPRX - Drawdown Comparison
The maximum KMT drawdown since its inception was -70.10%, smaller than the maximum CPRX drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for KMT and CPRX.
Loading charts...
Drawdown Indicators
| KMT | CPRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -70.10% | -94.25% | +24.15% |
Max Drawdown (1Y)Largest decline over 1 year | -26.25% | -13.91% | -12.34% |
Max Drawdown (3Y)Largest decline over 3 years | -42.95% | -27.29% | -15.66% |
Max Drawdown (5Y)Largest decline over 5 years | -52.70% | -45.37% | -7.33% |
Max Drawdown (10Y)Largest decline over 10 years | -69.28% | -64.87% | -4.41% |
Current DrawdownCurrent decline from peak | -21.07% | -0.03% | -21.04% |
Average DrawdownAverage peak-to-trough decline | -24.54% | -51.73% | +27.19% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.77% | 5.18% | +7.59% |
Volatility
KMT vs. CPRX - Volatility Comparison
Kennametal Inc. (KMT) has a higher volatility of 10.09% compared to Catalyst Pharmaceuticals, Inc. (CPRX) at 0.41%. This indicates that KMT's price experiences larger fluctuations and is considered to be riskier than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| KMT | CPRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.09% | 0.41% | +9.68% |
Volatility (6M)Calculated over the trailing 6-month period | 35.14% | 21.80% | +13.34% |
Volatility (1Y)Calculated over the trailing 1-year period | 46.88% | 31.77% | +15.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 37.17% | 47.65% | -10.48% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 40.91% | 59.86% | -18.95% |
Dividends
KMT vs. CPRX - Dividend Comparison
KMT's dividend yield for the trailing twelve months is around 2.36%, while CPRX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CPRX Catalyst Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
KMT Kennametal Inc. | 2.36% | 2.82% | 3.33% | 3.10% | 3.33% | 2.23% | 2.21% | 2.17% | 2.40% | 1.65% | 2.56% | 3.96% |
Financials
KMT vs. CPRX - Financials Comparison
This section allows you to compare key financial metrics between Kennametal Inc. and Catalyst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
KMT vs. CPRX - Profitability Comparison
KMT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Kennametal Inc. reported a gross profit of 206.38M and revenue of 592.61M. Therefore, the gross margin over that period was 34.8%.
CPRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Catalyst Pharmaceuticals, Inc. reported a gross profit of 0.00 and revenue of 149.39M. Therefore, the gross margin over that period was 0.0%.
KMT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Kennametal Inc. reported an operating income of 79.43M and revenue of 592.61M, resulting in an operating margin of 13.4%.
CPRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Catalyst Pharmaceuticals, Inc. reported an operating income of 73.23M and revenue of 149.39M, resulting in an operating margin of 49.0%.
KMT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Kennametal Inc. reported a net income of 58.23M and revenue of 592.61M, resulting in a net margin of 9.8%.
CPRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Catalyst Pharmaceuticals, Inc. reported a net income of 63.73M and revenue of 149.39M, resulting in a net margin of 42.7%.
Frequently Asked Questions
KMT and CPRX have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KMT has higher volatility (10.09%) compared to CPRX (0.41%). In terms of maximum drawdown, KMT dropped -70.10% vs CPRX's -94.25%.
CPRX currently has the higher Sharpe Ratio (1.54 vs 0.88), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for KMT and CPRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer